鼻内疫苗递送进展:一种有前景的非侵入性免疫接种途径
本文综述鼻内疫苗接种的关键进展,涵盖纳米颗粒系统(聚合物、多糖、脂质、蛋白体、脂肽、病毒体)作为载体或佐剂的设计与评价,以及临床前(体外和体内)和临床研究。鼻疫苗可额外激活上下呼吸道黏膜局部免疫细胞,无针给药利于持久免疫;甲型和乙型流感及乙型肝炎鼻疫苗已获卫生当局批准。
要点
- 鼻疫苗可激活上下呼吸道黏膜局部免疫细胞,并采用无针给药。
- 纳米颗粒系统(聚合物、多糖、脂质等)被广泛用于鼻疫苗的载体或佐剂。
- 甲型和乙型流感及乙型肝炎鼻疫苗已获卫生当局批准。
核心结论
- 鼻内疫苗接种是有前景的非侵入性免疫途径,纳米颗粒系统作为载体或佐剂可促进其发展。
研究设计与样本
- 本综述纳入并汇总了临床前(体外和体内)和临床研究,并对其及鼻内免疫的局限性进行批判性讨论。
主要发现
- 黏膜疫苗(如鼻疫苗)可额外激活上下呼吸道黏膜组织局部免疫细胞。
- 纳米颗粒系统(聚合物、多糖和脂质)以及蛋白体、脂肽和病毒体形式被广泛用于鼻疫苗的配方。
- 先进递送纳米系统已被设计和评价作为鼻疫苗接种的载体或佐剂。
- 若干纳米颗粒疫苗正作为鼻免疫的有前景候选者进行临床试验。
- 甲型和乙型流感及乙型肝炎鼻疫苗已获卫生当局批准。
关键数值与推荐
- 若干纳米颗粒疫苗正作为鼻免疫的有前景候选者进行临床试验。
- 甲型和乙型流感及乙型肝炎鼻疫苗已获卫生当局批准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 本文讨论了鼻内免疫的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The importance of vaccination has been proven particularly significant the last three years, as it is revealed to be the most efficient weapon for the prevention of several infections including SARS-COV-2. Parenteral vaccination is the most applicable method of immunization, for the prevention of systematic and respiratory infections, or central nervous system disorders, involving T and B cells to a whole-body immune response. However, the mucosal vaccines, such as nasal vaccines, can additionally activate the immune cells localized on the mucosal tissue of the upper and lower respiratory tract. This dual stimulation of the immune system, along with their needle-free administration favors the development of novel nasal vaccines to produce long-lasting immunity. In recent years, the nanoparticulate systems have been extensively involved in the formulation of nasal vaccines as polymeric, polysaccharide and lipid ones, as well as in the form of proteosomes, lipopeptides and virosomes. Advanced delivery nanosystems have been designed and evaluated as carriers or adjuvants for nasal vaccination. To this end, several nanoparticulate vaccines are undergone clinical trials as promising candidates for nasal immunization, while nasal vaccines against influenza type A and B and hepatitis B have been approved by health authorities. This comprehensive literature review aims to summarize the critical aspects of these formulations and highlight their potential for the future establishment of nasal vaccination. Both preclinical (in vitro and in vivo) and clinical studies are incorporated, summarized, and critically discussed, as well as the limitations of nasal immunization.
引用
- Kehagia E, Papakyriakopoulou P, Valsami G, et al. Advances in intranasal vaccine delivery: A promising non-invasive route of immunization. Vaccine. 2023. PMID: 37179163. doi:10.1016/j.vaccine.2023.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。